WO2003025015A3 - A soluble toll-like receptor - Google Patents

A soluble toll-like receptor Download PDF

Info

Publication number
WO2003025015A3
WO2003025015A3 PCT/EP2002/010410 EP0210410W WO03025015A3 WO 2003025015 A3 WO2003025015 A3 WO 2003025015A3 EP 0210410 W EP0210410 W EP 0210410W WO 03025015 A3 WO03025015 A3 WO 03025015A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptide
receptor
tlr
polypeptides
soluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2002/010410
Other languages
French (fr)
Other versions
WO2003025015A2 (en
Inventor
Eduardo Schiffrin
Michael Affolter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8178601&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2003025015(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Priority to EP02777127A priority Critical patent/EP1430133B1/en
Priority to US10/489,553 priority patent/US7230078B2/en
Priority to DE60219808T priority patent/DE60219808T2/en
Priority to AU2002338714A priority patent/AU2002338714B2/en
Priority to DK02777127T priority patent/DK1430133T3/en
Priority to JP2003528860A priority patent/JP4354812B2/en
Publication of WO2003025015A2 publication Critical patent/WO2003025015A2/en
Publication of WO2003025015A3 publication Critical patent/WO2003025015A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Paper (AREA)

Abstract

A novel, soluble protein similar to the known Toll-like receptor (TLR) family is disclosed. The present invention relates to these new soluble polypeptides, to nucleotide sequences encoding the polypeptides, to antibodies selectively binding to the polypeptide and to expression systems suitable for producing the polypeptide. The polypeptide is useful for modulating inflammatory reactions in mammals that include the actions of TLR.
PCT/EP2002/010410 2001-09-17 2002-09-13 A soluble toll-like receptor Ceased WO2003025015A2 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
EP02777127A EP1430133B1 (en) 2001-09-17 2002-09-13 A soluble toll-like receptor
US10/489,553 US7230078B2 (en) 2001-09-17 2002-09-13 Soluble toll-like receptor
DE60219808T DE60219808T2 (en) 2001-09-17 2002-09-13 A SOLUBLE GREAT-LIKE RECIPE
AU2002338714A AU2002338714B2 (en) 2001-09-17 2002-09-13 A soluble toll-like receptor
DK02777127T DK1430133T3 (en) 2001-09-17 2002-09-13 A soluble Toll-like receptor
JP2003528860A JP4354812B2 (en) 2001-09-17 2002-09-13 Soluble toll-like receptor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01121698A EP1293566A1 (en) 2001-09-17 2001-09-17 A soluble toll-like receptor
EP01121698.3 2001-09-17

Publications (2)

Publication Number Publication Date
WO2003025015A2 WO2003025015A2 (en) 2003-03-27
WO2003025015A3 true WO2003025015A3 (en) 2003-08-28

Family

ID=8178601

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2002/010410 Ceased WO2003025015A2 (en) 2001-09-17 2002-09-13 A soluble toll-like receptor

Country Status (10)

Country Link
US (1) US7230078B2 (en)
EP (2) EP1293566A1 (en)
JP (1) JP4354812B2 (en)
AT (1) ATE360694T1 (en)
AU (1) AU2002338714B2 (en)
DE (1) DE60219808T2 (en)
DK (1) DK1430133T3 (en)
ES (1) ES2286292T3 (en)
PT (1) PT1430133E (en)
WO (1) WO2003025015A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6303321B1 (en) * 1999-02-11 2001-10-16 North Shore-Long Island Jewish Research Institute Methods for diagnosing sepsis
US7304034B2 (en) 2001-05-15 2007-12-04 The Feinstein Institute For Medical Research Use of HMGB fragments as anti-inflammatory agents
US7696169B2 (en) * 2003-06-06 2010-04-13 The Feinstein Institute For Medical Research Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents
CA2882022A1 (en) * 2003-09-11 2005-03-24 Walter Newman Monoclonal antibodies against hmgb1
JP2006096752A (en) * 2004-08-31 2006-04-13 Ortho Corp Colostrum or colostrum-derived composition and method using colostrum or colostrum-drived composition
WO2007011606A2 (en) * 2005-07-18 2007-01-25 Critical Therapeutics, Inc. USE OF HMGBl ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY SKIN CONDITIONS
WO2007076200A2 (en) * 2005-11-28 2007-07-05 Medimmune, Inc. Antagonists of hmgb1 and/or rage and methods of use thereof
EP2139916A1 (en) * 2007-04-26 2010-01-06 Opsona Therapeutics Limited Toll-like receptor binding epitope and compositions for binding thereto
US20100278817A1 (en) * 2007-07-05 2010-11-04 Opsona Therapeutics Ltd. Compounds and methods for the treatment of renal disease
US8734788B2 (en) 2007-08-03 2014-05-27 Opsona Therapeutics Ltd Composition and method for treatment of reperfusion injury and tissue damage
US20100326218A1 (en) * 2007-09-27 2010-12-30 Michael Boeckh Identifying a subject with an increased risk of invasive mold infection
US20100136097A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems for modulating inflammation
US20100136095A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems for modulating inflammation
US20100136096A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems for modulating inflammation
US20100137247A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Anti-inflammatory compositions and methods
US20100136094A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems for modulating inflammation
US20100135983A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Anti-inflammatory compositions and methods
US20100137246A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Anti-inflammatory compositions and methods
GB201205633D0 (en) * 2012-03-30 2012-05-16 Opsona Therapeutics Ltd Toll-like receptor 2 binding epitope and binding members thereto

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0864585A1 (en) * 1997-03-12 1998-09-16 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18-receptor proteins
WO1999037772A1 (en) * 1998-01-23 1999-07-29 Immunex Corporation Il-18 receptors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0710477T3 (en) 1994-11-05 2001-11-05 Nestle Sa Lipid composition for cosmetic products
ES2298905T3 (en) * 1997-10-17 2008-05-16 Genentech, Inc. HOMOLOGOS OF HUMAN TYPE TOLL.
JP2000128900A (en) 1998-10-26 2000-05-09 Japan Science & Technology Corp Novel Toll-like receptor and its gene
WO2000075358A2 (en) 1999-06-04 2000-12-14 Millennium Pharmaceuticals, Inc. Mammalian toll homologues and uses thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0864585A1 (en) * 1997-03-12 1998-09-16 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18-receptor proteins
WO1999037772A1 (en) * 1998-01-23 1999-07-29 Immunex Corporation Il-18 receptors

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
DU ET AL.: "Analysis of Tlr4-mediated LPS signal transduction in macrophages by mutational modification of the receptor", BLOOD CELLS, MOLECULES AND DISEASES, vol. 25, no. 6, 15 November 1999 (1999-11-15), pages 328 - 338, XP002183507 *
FILIPP DOMINIK ET AL: "Soluble CD14 enriched in colostrum and milk induces B cell growth and differentiation.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 98, no. 2, 16 January 2001 (2001-01-16), January 16, 2001, pages 603 - 608, XP002187481, ISSN: 0027-8424 *
FLO T H ET AL: "Detection of soluble TLR2 in human serum samples by ELISA.", JOURNAL OF ENDOTOXIN RESEARCH, vol. 6, no. 2, 2000, 6th Conference of the International Endotoxin Society;Paris, France; August 24-27, 2000, pages 106, XP001052916, ISSN: 0968-0519 *
KOLB A F: "The prospects of modifying the antimicrobial properties of milk", BIOTECHNOLOGY ADVANCES, ELSEVIER PUBLISHING, BARKING, GB, vol. 19, no. 4, July 2001 (2001-07-01), pages 299 - 316, XP004274975, ISSN: 0734-9750 *
LABETA MARIO O ET AL: "Innate recognition of bacteria in human milk is mediated by a milk-derived highly expressed pattern recognition receptor, soluble CD14.", JOURNAL OF EXPERIMENTAL MEDICINE, vol. 191, no. 10, 15 May 2000 (2000-05-15), pages 1807 - 1812, XP002187480, ISSN: 0022-1007 *
MANTOVANI A ET AL: "Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines", TRENDS IN IMMUNOLOGY, ELSEVIER, CAMBRIDGE, GB, vol. 22, no. 6, 1 June 2001 (2001-06-01), pages 328 - 336, XP004249049, ISSN: 1471-4906 *
O'NEILL L A J ET AL: "The IL-1 receptor/toll-like receptor superfamily: crucial receptors for inflammation and host defense", IMMUNOLOGY TODAY, ELSEVIER PUBLICATIONS, CAMBRIDGE, GB, vol. 21, no. 5, May 2000 (2000-05-01), pages 206 - 209, XP004198146, ISSN: 0167-5699 *
PRUITT JEFFREY H ET AL: "Increased soluble interleukin-1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome.", BLOOD, vol. 87, no. 8, 1996, pages 3282 - 3288, XP001041460, ISSN: 0006-4971 *
XU YINGWU ET AL: "Structural basis for signal transduction by the Toll/interleukin-1 receptor domains.", NATURE (LONDON), vol. 408, no. 6808, 2000, pages 111 - 115, XP002183508, ISSN: 0028-0836 *

Also Published As

Publication number Publication date
JP2005511020A (en) 2005-04-28
WO2003025015A2 (en) 2003-03-27
US7230078B2 (en) 2007-06-12
JP4354812B2 (en) 2009-10-28
ATE360694T1 (en) 2007-05-15
US20050124538A1 (en) 2005-06-09
DE60219808T2 (en) 2008-01-17
AU2002338714B2 (en) 2007-06-14
EP1430133B1 (en) 2007-04-25
EP1430133A2 (en) 2004-06-23
DK1430133T3 (en) 2007-09-17
PT1430133E (en) 2007-07-27
EP1293566A1 (en) 2003-03-19
ES2286292T3 (en) 2007-12-01
DE60219808D1 (en) 2007-06-06

Similar Documents

Publication Publication Date Title
WO2003025015A3 (en) A soluble toll-like receptor
WO2002092771A3 (en) Specific binding proteins and uses thereof
BG104149A (en) INTERLevkin-18 Binding Proteins, Their Preparation and Administration
WO2005063816A3 (en) Monovalent antibody fragments useful as therapeutics
WO2000018932A3 (en) Receptor based antagonists and methods of making and using
EP1482040A3 (en) Nl3 tie receptor tyrosine kinase ligand homologues
WO2002002636A3 (en) Membrane associated protein zupari
WO2002102994A3 (en) Human secreted proteins
WO2005051998A3 (en) Antibodies binding to a c-terminal fragment of apolipoprotein e
WO2004039951A3 (en) Il-1 receptor based antagonists and methods of making and using
WO2000001815A3 (en) Neurotrophic factors
WO2004085648A3 (en) Nogo receptor binding protein
WO2002077186A3 (en) Human secreted proteins
WO2002024912A3 (en) Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22, and uses thereof
EP1607745A3 (en) Ligand for G-protein coupled receptor FPRL2 and uses thereof
WO2000039297A3 (en) Il-1 related polypeptides
WO2005012341A3 (en) Pichia methanolica secretory signal
WO2002002771A3 (en) Human sparc-homologous (hsparc-h1) gene and methods and uses thereof
WO2004053052A3 (en) HUMAN RECOMBINANT ENDOOLIGOPEPTIDASE A (hEOPA)
WO1999063093A3 (en) Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
WO2002046408A3 (en) Human proteins, polynucleotides encoding them and methods of using the same
WO2002081629A3 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
WO2003033675A3 (en) Identification of binding partners for specific proteins
EP0890647A3 (en) PcrA, novel polypeptide of the DNA helicases family
WO2002020786A3 (en) Kinase d interacting protein

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VN YU ZA ZM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2002338714

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2002777127

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10489553

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2003528860

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 2002777127

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 2002777127

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 2002338714

Country of ref document: AU